Nanocrystal Program

About NanoTech Pharma

NanoTech Pharma is a private, pre-revenue biotech firm founded in 2005, specializing in next-generation drug delivery platforms. Its pipeline features multiple preclinical and early clinical programs across its three core technology pillars—liposomes, LNPs, and nanocrystals—targeting oncology, infectious diseases, liver disease, and mental health disorders. The company's strategy centers on leveraging its proprietary AccuLNP® and nanocrystal systems to enhance drug performance, overcome biological barriers, and enable precision medicine approaches.

Therapeutic Areas